Page last updated: 2024-08-21

alpha-aminopyridine and Cockayne-Touraine Disease

alpha-aminopyridine has been researched along with Cockayne-Touraine Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atanasova, VS; Bruckner-Tuderman, L; Chen, M; Gruber, C; Has, C; Jiang, Q; McGrath, JA; Piñón Hofbauer, J; Prisco, M; South, AP; Uitto, J	1

Reviews

1 review(s) available for alpha-aminopyridine and Cockayne-Touraine Disease

Article	Year
Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa. The Journal of investigative dermatology, 2017, Volume: 137, Issue:9 Topics: Aminopyridines; Codon, Nonsense; Collagen Type VII; Epidermolysis Bullosa Dystrophica; Female; Gene Expression Regulation; Genes, Recessive; Genetic Predisposition to Disease; Humans; Male; Molecular Targeted Therapy; Mutation; Pedigree; Prognosis	2017

Article

Year

Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa.

The Journal of investigative dermatology, 2017, Volume: 137, Issue:9

Topics: Aminopyridines; Codon, Nonsense; Collagen Type VII; Epidermolysis Bullosa Dystrophica; Female; Gene Expression Regulation; Genes, Recessive; Genetic Predisposition to Disease; Humans; Male; Molecular Targeted Therapy; Mutation; Pedigree; Prognosis

2017